PresentationTerence FlynnEquity Analyst All right. Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's large-cap U.S. biopharma analyst. I'm very pleased to be hosting Moderna. We have Stéphane Bancel, who's the company's CEO. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. Stephane, thank you so much for joining ...